FDA Inspection 1119623 — Ophtapharm AG

Ophtapharm AG — FEI 3005531475

The FDA completed an inspection of Ophtapharm AG on Feb 28, 2020 in Winterthur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Veterinary.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 28, 2020
Fiscal Year
2020
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Winterthur (Switzerland)

Citations

IDCFRDescription
113421 CFR 211.25(b)Supervisor Training/Education/Experience
139521 CFR 211.103Actual vs. theoretical yields not determined
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.